ONCO

ONCO

USD

Onconetix Inc. Common Stock

$3.060-0.110 (-3.470%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$3.170

Haut

$3.170

Bas

$3.060

Volume

0.01M

Fondamentaux de l'Entreprise

Capitalisation Boursière

4.8M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.14M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $2.45Actuel $3.060Haut $251.6

Actualités Connexes

PR Newswire

Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms

Equity InsiderNews Commentary – Major pharmaceutical companies presenting at the European Society for Medical Oncology Congress October 17-21[1] are...

Voir plus
Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms
GlobeNewswire

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

CINCINNATI, OH, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc.

Voir plus
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.
GlobeNewswire

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

CINCINNATI, OH & FORT LEE, NJ, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc.

Voir plus
Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement